Literature DB >> 7859910

Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease.

P K Heinonen1, A Miettinen.   

Abstract

OBJECTIVE: To study the microbiologic findings in relation to the severity of acute pelvic inflammatory disease (PID). STUDY
DESIGN: Of 72 women with acute PID verified and graded by laparoscopy and endometrial histopathology, 37 had mild PID and 35 had severe PID. Cervical, endometrial and tubal cultures were obtained for Chlamydia trachomatis, Neisseria gonorrhoeae, genital mycoplasmas, facultative and anaerobic bacteria and herpes simplex virus.
RESULTS: C. trachomatis was the primary pathogenic agent in 44% of patients with acute PID. C. trachomatis and N. gonorrhoea were as common in both severity groups, although C. trachomatis was isolated significantly more frequently from the fallopian tubes among cases with severe PID. Where aerobic or facultative bacteria other than C. trachomatis or N. gonorrhoeae were concerned, Escherichia coli and Haemophilus influenzae were the most important aerobic bacteria isolated from the fallopian tubes. Anaerobic bacteria were recovered from the fallopian tubes significantly more frequently in cases with severe PID than in those with mild PID, whereas their presence in the endometrium was not related to the severity of PID.
CONCLUSIONS: The role of C. trachomatis as the leading cause of PID was confirmed in both laparoscopically mild and severe PID. Severe PID with abscess is invariably a polymicrobial infection with anaerobic bacteria involved, whereas their role in affecting the outcome of mild PID as well as the need of antianaerobic antimicrobial therapy in mild PID remains questionable.

Entities:  

Mesh:

Year:  1994        PMID: 7859910     DOI: 10.1016/0028-2243(94)90048-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  18 in total

1.  Perianal abscess due to Neisseria gonorrhoeae: an unusual case in the post-antibiotic era.

Authors:  Y El-Dhuwaib; B J Ammori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

2.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

3.  Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.

Authors:  Alison J Eastman; Ingrid L Bergin; Daniel Chai; Christine M Bassis; William LeBar; George O Oluoch; Emma R Liechty; Atunga Nyachieo; Vincent B Young; David M Aronoff; Dorothy L Patton; Jason D Bell
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope.

Authors:  Ye Zhu; Janina Jiang; Najwane Said-Sadier; Gale Boxx; Cheryl Champion; Ashley Tetlow; Valerie A Kickhoefer; Leonard H Rome; David M Ojcius; Kathleen A Kelly
Journal:  Vaccine       Date:  2014-11-24       Impact factor: 3.641

5.  Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents.

Authors:  Melinda A B Petrina; Lisa A Cosentino; Harold C Wiesenfeld; Toni Darville; Sharon L Hillier
Journal:  Anaerobe       Date:  2019-02-10       Impact factor: 3.331

6.  Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Toni Darville; Robert E Ferrell; Candace M Kammerer; Roberta B Ness; Catherine L Haggerty
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

7.  Management of Pelvic Inflammatory Disease in Selected U.S. Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.

Authors:  Eloisa Llata; Kyle T Bernstein; Roxanne P Kerani; Preeti Pathela; Jane R Schwebke; Christina Schumacher; Mark Stenger; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2015-08       Impact factor: 2.830

Review 8.  Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment.

Authors:  Caroline Mitchell; Malavika Prabhu
Journal:  Infect Dis Clin North Am       Date:  2013-10-31       Impact factor: 5.982

9.  Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.

Authors:  Brandie D Taylor; Catherine L Haggerty
Journal:  Infect Drug Resist       Date:  2011-01-20       Impact factor: 4.003

10.  Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.

Authors:  David Jacobson; Kathleen Moore; Camille Gunderson; Michelle Rowland; Rita Austin; Tanvi Prasad Honap; Jiawu Xu; Christina Warinner; Krithivasan Sankaranarayanan; Cecil M Lewis
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.